Powered by
-
GERN Stock Chart
Historical GERN Prices
Geron Corp Stock Analysis
Rating: Buy
Total Grade: B
Analysis Breakdown
| GERN Stock Grade: | B |
| Fundamental Grade: | C |
| Quantitative Grade: | A |
| GERN Earnings | |
| Earnings Growth: | C |
| Earnings Momentum: | B |
| Earnings Surprises: | D |
| Analyst Earnings Revisions: | F |
| GERN Financial Information | |
| Sales Growth: | B |
| Operating Margin Growth: | C |
| Cash Flow: | D |
| Return on Equity: | D |
Geron Corp Stock: Weekly View
| This Week: | B |
|---|---|
| Last Week: | B |
| Two Weeks Ago: | B |
GERN Stock predictions, Articles, and Geron Corp News
- From InvestorPlace
- From the Web
-
5 Top Stock Trades for Friday — BBBY, RAD and NFLX - September 27, 2018
Geron plunged almost 70% and Bed Bath & Beyond dropped more than 20%. Here are our top stock trades for Friday. Continue…
-
7 Biotech Stocks to Buy Now - September 19, 2018
Biotech companies are recovering nicely this year. With a quarter left to go, the upside potential is high for those biotech stocks that dipped recently. Continue…
-
Geron Corporation Stock Shoots Up on Job Posting News - August 24, 2018
Geron Corporation (GERN) stock went gangbusters on Friday as partner Johnson & Johnson (JNJ) opened a new job position for an EMEA Strategic Pricing Manager. Continue…
-
8 Undervalued Biotech Stocks to Watch - August 20, 2018
Volatility across all categories of biotech stocks makes this present juncture an ideal time to consider picking up undervalued names. Continue…
-
5 Risky, But Rewarding, Ways to Play the Rebound - February 7, 2018
These stocks and ETFs to buy have a good chance to give investors handsome rewards; however, they are not without significant risk. Continue…
-
24 Biotechnology Stocks to Sell Now - November 28, 2016
This week, the ratings of 24 Biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). Continue…
-
Gilead Sciences, Inc. (GILD) Stock Falters on Q3 Earnings Miss - November 2, 2016
Gilead Sciences (GILD) struggled in its third quarter thanks to lower Hepatitis C treatment sales. GILD stock is being punished as a result. Continue…
-
23 Biotechnology Stocks to Sell Now - September 26, 2016
This week, the overall grades of 23 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). Continue…
-
3 Battered Biotechs That Could Turn Things Around - September 23, 2016
Biotechs like NVAX, GERN and RGLS have made a name for themselves for all the wrong reasons, but they also have a chance at redemption. Continue…
-
Biggest Movers in Manufacturing Stocks Now – GALT CERC OVAS EBIO - September 21, 2016
The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers. Continue…
